NCT02795637View on ClinicalTrials.gov

Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)Binge-Eating Disorder Disorder

Interventions

DRUG

dasotraline

dasotraline 8mg capsule/day

Trial Locations (5)

30331

Atlanta Center for Medical Research, Atlanta

32809

Orlando Clinical Research Center, Orlando

55404

DaVita Clinical Research, Minneapolis

78215

American Research Cororation (ARC), Texas Liver Instituete (TLI), San Antonio

33014-3616

Clinical Pharmacology of Miami, Inc., Miami

All Listed Sponsors

lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT02795637 - Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction | Biotech Hunter | Biotech Hunter